The agreement covers Tristel ULT, an FDA-cleared disinfectant foam capable of eliminating bacteria, viruses, and fungi in two minutes. Designed for point-of-care application, the product eliminates the need for automated reprocessors and maintains compatibility with over 1,200 ultrasound probe models. Parker manufactures and distributes the foam through an exclusive partnership with the UK-based firm Tristel plc.
Beyond disinfection, the deal incorporates Parker’s broader ultrasound portfolio, including Aquasonic 100 transmission gel, UltraDrape barrier dressings, and Thermasonic gel warmers. Neal Buchalter, President of Parker Laboratories, noted that the partnership strengthens the company’s presence across Premier’s national healthcare network, facilitating wider adoption of their clinical supplies. Tom Rodenberg, Global Director of Sales, added that the contract serves to help providers improve patient safety and streamline diagnostic workflows.





Comments (0)
No comments yet. Be the first!